AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Rapid Micro Biosystems to Showcase Automation Solutions at H.C. Wainwright Global Investment Conference
ByAinvest
Wednesday, Sep 3, 2025 4:30 am ET1min read
Rapid Micro Biosystems will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025. The company specializes in automation solutions for healthcare product manufacturing and will showcase its innovative technologies that facilitate efficient manufacturing and safe release of healthcare products. Investors can access a live webcast through the company's investor relations website.
Rapid Micro Biosystems, Inc. (Nasdaq: RPID), an innovative life sciences technology company, has announced that it will present at the H.C. Wainwright 27th Annual Global Investment Conference in New York, NY. The presentation is scheduled for Tuesday, September 9, 2025, at 11:00 a.m. ET. Investors and financial professionals can access a live webcast of the presentation through the company's investor relations website at [https://investors.rapidmicrobio.com/](https://investors.rapidmicrobio.com/) [1][2].Rapid Micro Biosystems specializes in providing mission-critical automation solutions for healthcare product manufacturing. The company's flagship product, the Growth Direct system, automates and modernizes the microbial quality control (MQC) testing workflows used in large-scale pharmaceutical manufacturing operations. This system brings the quality control lab to the manufacturing floor, enhancing efficiency, accuracy, and compliance with data integrity regulations [1][2].
The company's headquarters are located in Lexington, Massachusetts, with U.S. manufacturing in Lowell, Massachusetts. Additionally, Rapid Micro Biosystems has global locations in Switzerland, Germany, and the Netherlands. For more information, investors can visit the company's website at [www.rapidmicrobio.com](http://www.rapidmicrobio.com) or follow the company on X (formerly known as Twitter) at [@rapidmicrobio](http://twitter.com/rapidmicrobio) or on LinkedIn [1][2].
References:
[1] https://www.globenewswire.com/news-release/2025/09/02/3143190/33206/en/Rapid-Micro-Biosystems-to-Present-at-the-H-C-Wainwright-27th-Annual-Global-Investment-Conference.html
[2] https://www.biospace.com/press-releases/rapid-micro-biosystems-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet